MBK Partners to Acquire Japanese Drugmaker Alinamin

SEOUL, Jul. 3 (Korea Bizwire) — Private equity firm MBK Partners will acquire Japan’s Alinamin Pharmaceutical for 2.9 trillion won (US$2.1 billion), industry sources said Wednesday. MBK Partners will buy the Japanese supplement maker from U.S. investment fund Blackstone in a stock purchase deal to be signed later in the day, according to the sources. [...]